Preclinical evaluation of antisense oligonucleotide therapy in a mouse model of <i>HNRNPH2</i> -related neurodevelopmental disorder

Authors

Institutions

Publication Details

Journal
Science Translational Medicine
Published
2026-04-22
DOI
https://doi.org/10.1126/scitranslmed.adx3491
Primary Topic
Genomics and Rare Diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Preclinical evaluation of antisense oligonucleotide therapy in a mouse model of HNRNPH2 -related neurodevelopmental disorder

Ané Korff, Anoop Kavirayani, A. Samanta, Alfonso Lavado et al.
Science Translational Medicine
Genomics and Rare Diseases
article

Preclinical evaluation of antisense oligonucleotide therapy in a mouse model of HNRNPH2 -related neurodevelopmental disorder

Ané Korff, Anoop Kavirayani, A. Samanta, Alfonso Lavado, Joseph Ochaba, Tushar Patni, Ozan Ozdemir, Yong‐Dong Wang, Hong Joo Kim, C. Frank Bennett, J. Paul Taylor, Berit Powers
article en

Abstract

No abstract available for this paper.
Science Translational MedicineVol. 18(846)
St. Jude Children's Research Hospital (US), Ionis Pharmaceuticals (United States) (US)
American Lebanese Syrian Associated Charities, National Institutes of Health
Openalex Percentile: Top 9%
Genomics and Rare Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.